Skuteczność liposomalnej cytarabiny w leczeniu pierwotnego i wtórnego zajęcia ośrodkowego układu nerwowego w przebiegu chłoniaków nieziarniczych - ocena retrospektywna pacjentów leczonych w Klinice Hematologii UJ CM

The treatment was well tolerated. Most of the associated adverse events (AE) were mild and moderate (grade 1-2 according to CTCAE); only 5.6% of AE were considered as severe. Headache was the most common complication; whereas cauda equina syndrome was considered as potentially the most dangerous condition. Transient cauda equina syndrome was observed in 1 patient (2.8% of all AEs).